Overview / Abstract: |
Psoriatic arthritis (PsA) can have serious debilitating effects on peripheral joints, the spine, tendon insertions, and fingers. Management of PsA has improved with therapies such as nonpharmacologic and symptomatic treatments, oral small molecules, tumor necrosis factor inhibitors, interleukin (IL)-12/23 inhibitors, IL-17 inhibitors, CTLA4-lg, Janus kinase (JAK)/TyK2 inhibitors, and IL-23 inhibitors; however, complete disease control has not yet been achieved. This CME Outfitters Snack focuses on evaluating the mechanistic rationale for novel and emerging treatments for PsA as well as assessing safety and efficacy data for current and emerging JAK inhibitors to determine their role in the management of PsA in order to help narrow the treatment gap. - Learning Objectives - At the end of this CE activity, participants should be able to: |
Expiration |
Feb 22, 2022 |
Discipline(s) |
Nurse Practitioner , Nursing CNE, Pharmacy CPE, Physician CME, Physician Assistant CME |
Format |
Online, Podcast, Webinar / Webcast / Video |
Credits / Hours |
.25 AMA PRA Category 1 Credit(s)™ |
Accreditation |
ACCME, AANP, ABIM, ACPE |
Presenters / Authors / Faculty |
Allan Gibofsky, MD, JD, MACR, FACP, FCLM Anthony Fernandez, MD, PhD |
Sponsors / Supporters / Grant Providers |
Supported by an educational grant from Bristol-Myers Squibb Company. |
Keywords / Search Terms |
CME Outfitters psoriasis, psoriatic arthritis, PsA, rheumatology, dermatology, rheumatologist, dermatologist, derm, rheum, joint pain, pain management, chronic pain, chronic illness, atopic dermatitis, meded, online, free, ABIM, ACPE, AANP, ACCME, arthritis Free CE CME |